{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T09:48:02Z","timestamp":1769161682758,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018920","name":"Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.bmc.2023.117440","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T12:01:23Z","timestamp":1691582483000},"page":"117440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Development of 3-acetylindole derivatives that selectively target BRPF1 as new inhibitors of receptor activator of NF-\u03baB ligand (RANKL)-Induced osteoclastogenesis"],"prefix":"10.1016","volume":"96","author":[{"given":"Wenqiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruonan","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yadong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1530-6830","authenticated-orcid":false,"given":"Min","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1900-8523","authenticated-orcid":false,"given":"Yu","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117440_b0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000223687","article-title":"Physiology of bone","volume":"16","author":"Grabowski","year":"2009","journal-title":"Endocrine Development"},{"key":"10.1016\/j.bmc.2023.117440_b0010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117440_b0015","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14348\/molcells.2017.0225","article-title":"Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation","volume":"40","author":"Park","year":"2017","journal-title":"Molecules and Cells"},{"key":"10.1016\/j.bmc.2023.117440_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jb\/mvv112","article-title":"The role of osteoclast differentiation and function in skeletal homeostasis","volume":"159","author":"Ikeda","year":"2016","journal-title":"Journal of Biochemistry"},{"key":"10.1016\/j.bmc.2023.117440_b0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","article-title":"The molecular understanding of osteoclast differentiation","volume":"40","author":"Asagiri","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bmc.2023.117440_b0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","article-title":"Osteoclast differentiation by RANKL and OPG signaling pathways","volume":"39","author":"Udagawa","year":"2021","journal-title":"Journal of Bone and Mineral Metabolism"},{"key":"10.1016\/j.bmc.2023.117440_b0035","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1021\/jm5007897","article-title":"Modified salicylanilide and 3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-dione derivatives as novel inhibitors of osteoclast differentiation and bone resorption","volume":"57","author":"Chen","year":"2014","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2023.117440_b0040","doi-asserted-by":"crossref","first-page":"12043","DOI":"10.1021\/acs.jmedchem.0c01316","article-title":"Discovery of Small-Molecule Inhibitors of Receptor Activator of Nuclear Factor-kappaB Ligand with a Superior Therapeutic Index","volume":"63","author":"Rinotas","year":"2020","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2023.117440_b0045","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0749-0690(02)00069-1","article-title":"Bisphosphonate treatment of osteoporosis","volume":"19","author":"Watts","year":"2003","journal-title":"Clinics in Geriatric Medicine"},{"key":"10.1016\/j.bmc.2023.117440_b0050","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2165\/00002018-200730090-00003","article-title":"Safety considerations with bisphosphonates for the treatment of osteoporosis","volume":"30","author":"Strampel","year":"2007","journal-title":"Drug Safety"},{"key":"10.1016\/j.bmc.2023.117440_b0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1634\/theoncologist.9-90004-28","article-title":"Safety of intravenous and oral bisphosphonates and compliance with dosing regimens","volume":"9","author":"Conte","year":"2004","journal-title":"The Oncologist"},{"key":"10.1016\/j.bmc.2023.117440_b0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1470-0328(02)02952-X","article-title":"A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol and norethisterone acetate","volume":"110","author":"Neven","year":"2003","journal-title":"BJOG : An International Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.bmc.2023.117440_b0065","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/14740338.2015.1014799","article-title":"Selective estrogen receptor modulators in clinical practice: a safety overview","volume":"14","author":"Ellis","year":"2015","journal-title":"Expert Opinion on Drug Safety"},{"key":"10.1016\/j.bmc.2023.117440_b0070","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1021\/acs.jmedchem.7b00611","article-title":"Design of a chemical probe for the bromodomain and plant homeodomain finger-containing (BRPF) family of proteins","volume":"60","author":"Igoe","year":"2017","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2023.117440_b0075","doi-asserted-by":"crossref","unstructured":"Cochran AG, Conery AR. Sims RJ, 3rd. Bromodomains: a new target class for drug development. Nature Reviews Drug Discovery 2019;18:609-628.","DOI":"10.1038\/s41573-019-0030-7"},{"key":"10.1016\/j.bmc.2023.117440_b0080","article-title":"Bromodomains as therapeutic targets","author":"Muller","year":"20111329","journal-title":"Expert Reviews in Molecular Medicine"},{"key":"10.1016\/j.bmc.2023.117440_b0085","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.1021\/jm300346w","article-title":"Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites","volume":"55","author":"Vidler","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2023.117440_b0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1146\/annurev.biochem.76.052705.162114","article-title":"Functions of site-specific histone acetylation and deacetylation","volume":"76","author":"Shahbazian","year":"2007","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/j.bmc.2023.117440_b0095","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/20974","article-title":"Structure and ligand of a histone acetyltransferase bromodomain","volume":"399","author":"Dhalluin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117440_b0100","first-page":"659","article-title":"The role of human bromodomains in chromatin biology and gene transcription","volume":"12","author":"Sanchez","year":"2009","journal-title":"Current Opinion in Drug Discovery & Development"},{"key":"10.1016\/j.bmc.2023.117440_b0105","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cell.2012.02.013","article-title":"Histone recognition and large-scale structural analysis of the human bromodomain family","volume":"149","author":"Filippakopoulos","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2023.117440_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112338","article-title":"Design, synthesis, and biological evaluation of dual targeting inhibitors of histone deacetylase 6\/8 and bromodomain BRPF1","volume":"200","author":"Ghazy","year":"2020","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2023.117440_b0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12185-013-1466-x","article-title":"Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion","volume":"99","author":"Shima","year":"2014","journal-title":"International Journal of Hematology"},{"key":"10.1016\/j.bmc.2023.117440_b0120","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/acsmedchemlett.6b00092","article-title":"GSK6853, a chemical probe for inhibition of the BRPF1 bromodomain","volume":"7","author":"Bamborough","year":"2016","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"10.1016\/j.bmc.2023.117440_b0125","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1021\/acs.jmedchem.5b00405","article-title":"Structure-guided design of IACS-9571, a selective high-affinity dual TRIM24-BRPF1 bromodomain inhibitor","volume":"59","author":"Palmer","year":"2016","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2023.117440_b0130","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1021\/acs.jmedchem.6b01583","article-title":"Design of a biased potent small molecule inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) proteins suitable for cellular and in vivo studies","volume":"60","author":"Igoe","year":"2017","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2023.117440_b0135","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1021\/acs.jmedchem.5b00458","article-title":"Discovery of a chemical tool inhibitor targeting the bromodomains of TRIM24 and BRPF","volume":"59","author":"Bennett","year":"2016","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2023.117440_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133147","article-title":"Bone remodeling: histone modifications as fate determinants of bone cell differentiation","volume":"20","author":"Yi","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.bmc.2023.117440_b0145","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1021\/acschembio.7b00481","article-title":"Selective Targeting of Bromodomains of the Bromodomain-PHD Fingers Family Impairs Osteoclast Differentiation","volume":"12","author":"Meier","year":"2017","journal-title":"ACS Chemical Biology"},{"key":"10.1016\/j.bmc.2023.117440_b0150","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1021\/acs.jmedchem.6b00215","article-title":"Twenty crystal structures of bromodomain and PHD finger containing protein 1 (BRPF1)\/ligand complexes reveal conserved binding motifs and rare interactions","volume":"59","author":"Zhu","year":"2016","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2023.117440_b0155","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1021\/ci060155b","article-title":"Novel 2D fingerprints for ligand-based virtual screening","volume":"46","author":"Ewing","year":"2006","journal-title":"Journal of Chemical Information and Modeling"},{"key":"10.1016\/j.bmc.2023.117440_b0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ddtec.2016.09.001","article-title":"Structural features and inhibitors of bromodomains","volume":"19","author":"Meslamani","year":"2016","journal-title":"Drug Discovery Today: Technologies"},{"key":"10.1016\/j.bmc.2023.117440_b0165","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41419-021-03939-7","article-title":"A novel BRD4 inhibitor suppresses osteoclastogenesis and ovariectomized osteoporosis by blocking RANKL-mediated MAPK and NF-kappaB pathways","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.bmc.2023.117440_b0170","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1021\/acs.jmedchem.8b02027","article-title":"Development of small-molecules targeting receptor activator of nuclear factor-kappaB ligand (RANKL)-receptor activator of nuclear factor-kappaB (RANK) protein-protein interaction by structure-based virtual screening and hit optimization","volume":"62","author":"Jiang","year":"2019","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.bmc.2023.117440_b0175","first-page":"3","article-title":"Isolation and generation of osteoclasts","volume":"2019","author":"Rucci","year":"1914","journal-title":"Methods in Molecular Biology"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623002882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623002882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:24:15Z","timestamp":1760837055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623002882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":35,"alternative-id":["S0968089623002882"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117440","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of 3-acetylindole derivatives that selectively target BRPF1 as new inhibitors of receptor activator of NF-\u03baB ligand (RANKL)-Induced osteoclastogenesis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117440"}}